咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >SCHISTOX: An individual based ... 收藏

SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis

作     者:Matthew Graham Diepreye Ayabina Tim CD.Lucas Benjamin S.Collyer Graham F.Medley T.Deirdre Hollingsworth Jaspreet Toor 

作者机构:Big Data InstituteLi Ka Shing Centre for Health Information and DiscoveryUniversity of OxfordOxfordUnited Kingdom Centre for Mathematical Modelling of Infectious DiseaseLondon School of Hygiene and Tropical MedicineLondonUnited Kingdom Centre for Environment and HealthImperial College LondonLondonUnited Kingdom Department of Infectious Disease EpidemiologySchool of Public HealthFaculty of MedicineSt Mary’s CampusImperial College LondonUnited Kingdom MRC Centre for Global Infectious Disease Analysisthe Abdul Latif Jameel Institute for Disease and Emergency Analytics(J-IDEA)School of Public HealthImperial College LondonLondonW21PGUnited Kingdom 

出 版 物:《Infectious Disease Modelling》 (传染病建模(英文))

年 卷 期:2021年第6卷第1期

页      面:438-447页

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基  金:All authors gratefully acknowledge funding of the NTD Modelling Consortium by the Bill and Melinda Gates Foundation[OPP1184344] 

主  题:Schistosomiasis Individual based model Mass drug administration 

摘      要:A stochastic individual based model,SCHISTOX,has been developed for the study of schistosome transmission dynamics and the impact of control by mass drug *** novel aspects that can be investigated include individual level adherence and access to treatment,multiple communities,human sex population dynamics,and implementation of a potential *** of the model parameters have been estimated within previous studies and have been shown to vary between communities,such as the age-specific contact rates governing the age profiles of ***,uncertainty remains as there are wide ranges for certain parameter values and a few remain relatively *** analyse the model dynamics by parameterizing it with published parameter *** also discuss the development of SCHISTOX in the form of a publicly available open-source GitHub *** next key development stage involves validating the model by calibrating to epidemiological data.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分